Amarin Provides Preliminary 2020 Results and 2021 Outlook
Unaudited 2020 Total Net Revenue Estimated to Be Approximately $610 Million, an Increase of Approximately 42% Compared with 2019...…
Börse:
1,664$
0,25%
Echtzeit-Aktienkurs Amarin Corp. PLC (Spons. ADRs)
Bid:
1,633$
Ask:
1,696$
Nachrichten zur Amarin Corp. PLC (Spons. ADRs) Aktie
This Stock Could Be a Surprise Growth Pick for 2021
Down 77% in 2020, Amarins stock should zoom higher once Vascepa obtains European approval....…
Amarin to Present at 39th Annual J.P. Morgan Healthcare Conference
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today that…
Amarin (AMRN) Surges: Stock Moves 9% Higher
Amarin (AMRN) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes....…
Amarin: Kursziel verringert
New York (www.aktiencheck.de) - Rating-Update:
Paul Choi, Analyst von Goldman Sachs, stuft die Aktie von Amarin Corporation plc (ISIN: US0231112063, WKN:…
Amarin up 7% on encouraging Vascepa data in COVID-19 and cardiovascular events
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results
REDUCE-IT® EPA Encore Presentation reinforces Eicosapentaenoic Acid (EPA) levels from VASCEPA® (icosapent ethyl) strongly correlated to cardiovascular outcomes, more so…
Amarin Reports Encouraging Efficacy and Safety Results from Pilot Study Treating COVID-19 Infected Outpatients with VASCEPA® (Icosapent Ethyl) in Late Breaker Presentation at National Lipid Association (NLA) Scientific Sessions 2020
VASCEPA COVID-19 CardioLink-9 Randomized Trial suggests improvement in patient-reported COVID-19 symptoms while achieving its primary endpoint by demonstrating a 25%…
Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately....…
Amarin (AMRN) Investor Presentation - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Corporation plc (AMRN) CEO John Thero Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference Call - (Transcript)
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit
Heres a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week…
Amarin Files Patent Infringement Lawsuit Against Hikma
DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), announced today the…
Amarin vs. the Generics: Who Will Win?
After Amarin lost its patent rights in the U.S., the stock crashed overnight. Investors might want to stay optimistic....…
ROCE Insights For Amarin Corp
During Q3, Amarin Corp (NASDAQ: AMRN) brought in sales totaling $156.50 million. However, earnings decreased 266.99%, resulting in a loss…
Amarin Jumps on Heart-Drug Progress in China Trial
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
Heres a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week…
Amarin stock rise 23% on positive late-stage data in VASCEPA trial in China
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Corporation PLC (AMRN) Presents at Jefferies Virtual London Healthcare Broker Conference Call - (Transcript)
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Corporation plc (AMRN) Presents at Stifel Virtual Healthcare Conference (Transcript)
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences
DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that…
Amarin Corporation plc 2020 Q3 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin (AMRN) Q3 2020 Earnings Call Transcript
AMRN earnings call for the period ending September 30, 2020....…
Amarin Corporation plc (AMRN) CEO John Thero on Q3 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin slips 4% on Q3 results; top-line +39%
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AMARIN CORP PLCUK: 10-Q Report
10-Q...…
AMARIN CORP PLCUK: 8-K Report
8-K...…
These 3 Stocks Are Trading at Ludicrous P/E Ratios. Should Investors Avoid Them?
Heres why the stock prices of Tesla, Zoom, and Amarin are being driven by overexuberant speculation....…
The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs
Heres a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week…
Amarin gains after Vascepa found to significantly reduce ischemic events in PCI patients
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately....…
Thinking about buying stock in Ion Geophysical, TPI Composites, Coty, Tilray, or Amarin Corp?
NEW YORK , Oct. 8, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IO,…
Unusual Options Activity Insight: Amarin Corp
On Tuesday, shares of Amarin Corp (NASDAQ: AMRN) saw unusual options activity. After the option alert, the stock price moved…
Thinking about buying stock in ImmunoGen, Lithium Americas Corp, Cytokinetics, Kosmos Energy, or Amarin Corp?
NEW YORK , Oct. 5, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…
Amarin (AMRN) Investor Presentation - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Corporation plc (AMRN) CEO John Thero Presents at Cantor Virtual Global Healthcare Conference (Transcript)
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Is A Good Contrarian Pick To Consider After Post-Appeal Sell-Off
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Loses Patent Appeal in Vascepa Lawsuit, Stock Dips
Amarin (AMRN) receives a setback as the U.S. Court of Appeals upholds a ruling by Nevada district court in favor…
Amarin Shares Sink As Generic Competition for Fish Oil Heart Drug Looks More Certain
The air keeps leaking out of Amarin, a once-hot stock that captured the imaginations of investors with a proprietary fish…
Amarin Sinks to Five-Month Low After Losing Ruling on Heart Drug
Amarin Loses Appeals Court Ruling Over Vascepa Heart Drug...…
AMARIN CORP PLCUK: 8-K Report
8-K...…
Appeals Court Rules Against Amarin in Vascepa Patent Dispute
Just one day after hearing arguments, the U.S. Court of Appeals delivered a ruling that Amarin shareholders did not want…
Amarin Loses Appeal in Heart Treatment Patent Case
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin to contest appeals court panel decision on Vascapa patents
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin to contest appeals court decision on Vascapa patents
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amarin Provides Update Following Ruling in VASCEPA® ANDA Patent Litigation
DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today provided an…
Amarin Loses Appeals Court Ruling Over Vascepa Heart Drug
Amarin Loses Appeals Court Ruling Over Vascepa Heart Drug...…
Return On Capital Employed Overview: Amarin Corp
Amarin Corp (NASDAQ: AMRN) posted Q2 earnings of $4.16 million, an increase from Q1 of 117.3%. Sales dropped to $135.32…
Amarin loses appeals court ruling on Vascepa
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch
Todays Daily Dose brings you news about Applied Genetics upcoming presentation, oral arguments in patent suits of Amarin and Corcept,…